Stock Information
United Therapeutics Corp (UTHR)
Ticker Symbol: UTHR
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $20,697.45 mil
Piotroski score: 6
PE Ratio: 15.52
EPS (TTM): 27.96
Revenue (TTM): $68.88 M
Dividend Yield: N/A
ROE: 20.18%
Latest News
-
United Therapeutics (UTHR): Goldman Says Sell As The Base Business Shrinks, But 2027 Holds Real Catalysts
Tue, Sep 29, 2026 1:44 AM
-
What United Therapeutics (UTHR)'s Goldman Sell Call Amid Bold Pipeline And Buyback Means For Shareholders
Sun, Sep 27, 2026 7:10 PM
-
United Therapeutics (UTHR) Falls On Goldman Sell Call, Is It Still 29% Undervalued?
Sun, Sep 27, 2026 2:08 PM
-
United Therapeutics: The Market Sees The Erosion, Not The Refill - Buy
Sun, Sep 27, 2026 10:44 AM
-
United Therapeutics Maps 14 Launches, Fibrosis Growth and Xenokidney Ambitions
Fri, Sep 25, 2026 10:02 AM
-
Why United Therapeutics (UTHR) Shares Are Falling Today
Fri, Sep 25, 2026 1:12 AM
-
Microsoft reinstated, Ralph Lauren upgraded: Wall Street's top analyst calls
Thu, Sep 24, 2026 1:41 PM
-
United Therapeutics (NASDAQ:UTHR): A Growth-at-a-Reasonable-Price Candidate
Thu, Sep 24, 2026 11:21 AM
-
Goldman Sachs Initiates Coverage On United Therapeutics with Sell Rating, Announces Price Target of $321
Thu, Sep 24, 2026 9:44 AM
-
United Therapeutics Corporation (UTHR) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript
Wed, Sep 23, 2026 6:49 PM
Key Financials
Financial data not available
